CAPR
Capricor Therapeutics Inc
Price:
9.56
USD
Volume:
4,790,685
United States | Biotechnology
CAPR Net Margin
As of 2025-05-16, the Net Margin of Capricor Therapeutics Inc (CAPR) is -181.7%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
CAPR Net Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | -181.7% |
| 2023-12-31 | -88.5% |
| 2022-12-31 | -1138% |
| 2021-12-31 | -8341.7% |
| 2020-12-31 | -4406.4% |
| 2019-12-31 | -756.4% |
| 2018-12-31 | -909.6% |
| 2017-12-31 | 91% |
| 2016-12-31 | -470.2% |
| 2015-12-31 | -233% |
CAPR Net Margin - Peers Comparison